omega-n-methylarginine has been researched along with n-(3-(aminomethyl)benzyl)acetamidine in 12 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (n-(3-(aminomethyl)benzyl)acetamidine) | Trials (n-(3-(aminomethyl)benzyl)acetamidine) | Recent Studies (post-2010) (n-(3-(aminomethyl)benzyl)acetamidine) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 328 | 1 | 106 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | n-(3-(aminomethyl)benzyl)acetamidine (IC50) |
|---|---|---|---|
| Nitric oxide synthase, brain | Homo sapiens (human) | 4.89 | |
| Nitric oxide synthase, brain | Rattus norvegicus (Norway rat) | 7.55 | |
| Nitric oxide synthase, inducible | Mus musculus (house mouse) | 0.177 | |
| Nitric oxide synthase, inducible | Homo sapiens (human) | 0.1395 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 9 (75.00) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, H; Martasek, P; Masters, BS; Roman, LJ; Silverman, RB | 1 |
| Hamilton, LC; Warner, TD | 1 |
| Dugas, B; Dugas, N; Fourneau, JM; Kolb, JP; Marconi, A; Roman, V; Sigaux, F; Zhao, H | 1 |
| Gilroy, DW; Paul-Clark, MJ; Tomlinson, A; Willis, D; Willoughby, DA | 1 |
| Fermor, B; Fink, C; Guilak, F; LeGrand, A; Pisetsky, DS; Vail, TP; Weinberg, JB | 1 |
| Grant, AL; Hagan, RM; Starkey, SJ | 1 |
| Slomiany, A; Slomiany, BL | 1 |
| Abe, K; Chiba, Y; Matsuo, K; Misawa, M; Sakai, H | 1 |
| Mayr, FB; Spiel, AO | 1 |
| Boer, R; Ghofrani, HA; Grimminger, F; Lehner, M; Maring, D; Mayer, K; Pullamsetti, SS; Rosengarten, B; Schermuly, RT; Schudt, C; Seeger, W; Weissmann, N | 1 |
| Diesen, DL; Hess, DT; Stamler, JS | 1 |
| Astiz, ME; Berna, G; Griffin, K; Khan, R; Kirschenbaum, LA; LaRow, C | 1 |
12 other study(ies) available for omega-n-methylarginine and n-(3-(aminomethyl)benzyl)acetamidine
| Article | Year |
|---|---|
N(omega)-Nitroarginine-containing dipeptide amides. Potent and highly selective inhibitors of neuronal nitric oxide synthase.
Topics: Animals; Cattle; Dipeptides; Enzyme Inhibitors; Mice; Neurons; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitroarginine; Rats | 1999 |
Interactions between inducible isoforms of nitric oxide synthase and cyclo-oxygenase in vivo: investigations using the selective inhibitors, 1400W and celecoxib.
Topics: 6-Ketoprostaglandin F1 alpha; Amidines; Analysis of Variance; Aniline Compounds; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzylamines; Celecoxib; Crotonates; Cyclooxygenase 2; Dexamethasone; Diclofenac; Enzyme Inhibitors; Hydroxybutyrates; Isoenzymes; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitriles; Nitrites; Nitrogen Dioxide; omega-N-Methylarginine; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Wistar; Sulfonamides; Toluidines | 1998 |
Expression of a functional inducible nitric oxide synthase in hairy cell leukaemia and ESKOL cell line.
Topics: Amidines; Antibodies, Monoclonal; Apoptosis; Arginine; Benzylamines; Blotting, Western; Enzyme Induction; Enzyme Inhibitors; Fluorescent Dyes; Gene Expression Regulation, Leukemic; Humans; Leukemia, Hairy Cell; Microscopy, Fluorescence; Neoplasm Proteins; Neoplastic Stem Cells; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; omega-N-Methylarginine; Receptors, IgE; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured | 2000 |
Nitric oxide synthase inhibitors have opposite effects on acute inflammation depending on their route of administration.
Topics: Acute Disease; Amidines; Animals; Antioxidants; Benzylamines; Carrageenan; Disease Models, Animal; Drug Administration Schedule; Edema; Enzyme Inhibitors; Free Radical Scavengers; Inflammation; Inflammation Mediators; Injections; Injections, Intraperitoneal; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Pleura; Pleurisy; Rats; Rats, Wistar; Superoxides; Thiourea | 2001 |
Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci.
Topics: Aged; Amidines; Benzylamines; Cell Survival; Cells, Cultured; Cyclooxygenase Inhibitors; Cytokines; Dinoprostone; Drug Synergism; Enzyme Inhibitors; Humans; Interleukin-1; Interleukin-17; Menisci, Tibial; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Nitrobenzenes; omega-N-Methylarginine; Osteoarthritis, Knee; Sulfonamides; Tumor Necrosis Factor-alpha | 2001 |
A rapid and transient synthesis of nitric oxide (NO) by a constitutively expressed type II NO synthase in the guinea-pig suprachiasmatic nucleus.
Topics: Amidines; Animals; Benzylamines; Calcium; Dose-Response Relationship, Drug; Electrochemistry; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Guinea Pigs; In Vitro Techniques; Lipopolysaccharides; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; omega-N-Methylarginine; Oxidation-Reduction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Suprachiasmatic Nucleus; Tissue Distribution | 2001 |
Platelet-activating factor mediates Porphyromonas gingivalis lipopolysaccharide interference with salivary mucin synthesis via phosphatidylinositol 3-kinase-dependent constitutive nitric-oxide synthase activation.
Topics: Amidines; Androstadienes; Animals; Apoptosis; Benzylamines; Cell Survival; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Ginkgolides; Glucosamine; Lactones; Lipopolysaccharides; Mucins; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Platelet Activating Factor; Porphyromonas gingivalis; Rats; Rats, Sprague-Dawley; Saliva; Salivary Glands; Sublingual Gland; Tritium; Tumor Necrosis Factor-alpha; Up-Regulation; Wortmannin | 2004 |
Effects of 1400W, a potent selective inducible NOS inhibitor, on histamine- and leukotriene D4-induced relaxation of isolated guinea pig nasal mucosa.
Topics: Amidines; Animals; Benzylamines; Enzyme Inhibitors; Guinea Pigs; Histamine; Leukotriene D4; Nasal Mucosa; Nitric Acid; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Vasodilation | 2006 |
NO-synthase inhibition in sepsis.
Topics: Amidines; Animals; Benzylamines; Disease Models, Animal; Enzyme Inhibitors; Hemodynamics; Humans; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Sepsis; Shock, Septic | 2006 |
Effect of nitric oxide synthase (NOS) inhibition on macro- and microcirculation in a model of rat endotoxic shock.
Topics: Amidines; Animals; Benzylamines; Disease Models, Animal; Enzyme Inhibitors; Epinephrine; Hemoglobins; Male; Microcirculation; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Rats; Rats, Wistar; Shock, Septic | 2006 |
Hypoxic vasodilation by red blood cells: evidence for an s-nitrosothiol-based signal.
Topics: Amidines; Animals; Aorta; Benzylamines; Endothelium, Vascular; Enzyme Inhibitors; Erythrocytes; Hemoglobins; Humans; Hypoxia; In Vitro Techniques; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Nitrogen; omega-N-Methylarginine; Oxyhemoglobins; Rabbits; Regional Blood Flow; Signal Transduction; Vasoconstriction; Vasodilation | 2008 |
Augmentation of platelet and endothelial cell eNOS activity decreases sepsis-related neutrophil-endothelial cell interactions.
Topics: Adult; Aged; Arginine; Endothelial Cells; Humans; Imines; Middle Aged; Neutrophils; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Platelet Activation; Platelet Aggregation; Shock, Septic | 2010 |